Archaeosome immunostimulatory vaccine delivery system

Current Drug Delivery

Volumn 2, Issue 4, 2005, Pages 407-421

  Patel, Girishchandra B ^a   Chen, Wangxue ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

Adjuvant; Antibody; Archaeosome; Cell mediated immunity; CTL; Liposome; Vaccine delivery

Indexed keywords

ANTIGEN; ARCHEASOME; ESTER; FREUND ADJUVANT; IMMUNOLOGICAL ADJUVANT; LIPID; LIPOSOME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RECOMBINANT VACCINE; UNCLASSIFIED DRUG;

ANTIBODY RESPONSE; ANTIGEN PRESENTING CELL; ARCHAEBACTERIUM; ARTICLE; BACTERIAL INFECTION; CANCER; CELLULAR IMMUNITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG STABILITY; DRUG STRUCTURE; HUMORAL IMMUNITY; IMMUNOSTIMULATION; NONHUMAN; PHAGOCYTE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ARCHAEA; CHEMISTRY, PHYSICAL; DRUG DELIVERY SYSTEMS; HUMANS; LIPIDS; LIPOSOMES; VACCINES;

EID: 24644519461     PISSN: 15672018     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720105774370285     Document Type: Article

References (85)

1. Patel, G. B.; Sprott, G. D. Crit Rev. Biotechnol. 1999, 19, 317-357.
2. Boone, D. R.; Whitman, W. B.; Rouviere, P. In Methanogenesis, Ferry, J. G., Ed.; Chapman & Hall: New York, 1993; pp. 35-80.
3. Madigan, M. T.; Marrs, B. L. Sci. Am. 1997, 276, 82-87.
4. Sprott, G. D.; Patel, G. B.; Krishnan, L. Methods Enzymol. 2003, 373, 155-172.
5. Sprott, G. D.; Choquet, C. G.; Patel, G. B. In Methanogens. Archaea-A Laboratory Manual Sowers, K. R.; Schreier, H. J., Ed.; Cold Spring Harbor Laboratory Press: New York, 1995; pp. 329-340.
6. De Rosa, M.; Gambacorta, A. Prog. Lipid Res. 1988, 27, 153-175.
7. Sprott, G. D. J Bioenerg. Biomembr. 1992, 24, 555-566.
8. Kates, M. Am. Chem. Soc. Symp. Series 1997, 671, 35-47.
9. Kates, M. Biochem. Soc. Symp. 1992, 58, 51-72.
10. Szoka, F., Jr.; Papahadjopoulos, D. Annu. Rev. Biophys. Bioeng. 1980, 9, 467-508.
11. Weiner, A. L.; Cannon, J. B.; Tyle, P. In Controlled Release of Drugs: Polymers and Aggregate Systems, Rosoff, M., Ed.; VCH Publishers: New York, 1989; pp. 217-252.
12. Betageri, G. V.; Jenkins, S. A.; Parsons, D. L. Liposome Drug Delivery Systems.; Technomic Publishing Co., Inc.: Lancaster, PA, 1993.
13. Watwe, R. M.; Bellare, J. R. Curr. Sci. 1995, 68, 715-724.
14. Choquet, C. G.; Patel, G. B.; Beveridge, T. J.; Sprott, G. D. Appl. Microbiol. Biotechnol. 1994, 42, 375-384.
15. Makabi-Panzu, B.; Sprott, G. D.; Patel, G. B. Vaccine 1998, 16, 1504-1510.
16. Patel, G. B.; Omri, A.; Deschatelets, L.; Sprott, G. D. J. Liposome Res. 2002, 12, 353-372.
17. Lo, S. L.; Chang, E. L. Biochem. Biophys. Res. Commun. 1990, 167, 238-243.
18. Freisleben, H. J.; Bormann, J.; Litzinger, D. C.; Lehr, F.; Rudolph, P.; Schatton, W.; Huang, L. J. Liposome Res. 1995, 5, 215-223.
19. Ring, K.; Henkel, B.; Valenteijn, A.; Gutermann, R. In Liposomes as Drug Carriers, Schmidt, K. H., Ed.; Thieme: Stuttgart, 1986; pp. 101-123.
20. Sprott, G. D.; Patel, G. B.; Makabi-Panzu, B.; Tolson, D. L. PCT International Publication No. WO97/22333, 1997.
21. Sprott, G. D.; Dicaire, C. J.; Fleming, L. P.; Patel, G. B. Cells and Materials 1996, 6, 143-155.
22. Lelkes, P. I.; Goldenberg, D.; Gliozzi, A.; De Rosa, M.; Gambacorta, A.; Miller, I. R. Biochim. Biophys. Acta 1983, 732, 714-718.
23. Mirghani, Z.; Bertoia, D.; Piano, E.; Gliozzi, A. Biochem. Soc. Trans. 1989, 17, 507-508.
24. New, R. R. C. In Liposomes: A Practical Approach, New, R. R. C., Ed.; IRL Press at Oxford University Press: Oxford, 1990; pp. 33-104.
25. Chen, J. S.; Barton, P. G.; Brown, D.; Kates, M. Biochim. Biophys. Acta 1974, 352, 202-217.
26. Blocher, D.; Six, L.; Gutermann, R.; Henkel, B.; Ring, K. Biochim. Biophys. Acta 1985, 818, 333-342.
27. Patel, G. B.; Agnew, B. J.; Jarrell, H. C.; Sprott, G. D. J. Liposome Res. 1999, 9, 229-245.
28. Ausborn, M.; Nuhn, P.; Schreier, H. J. Eur. J. Pharm. Biopharm. 1992, 38, 133-139.
29. Beveridge, T. J.; Choquet, C. G.; Patel, G. B.; Sprott, G. D. J. Bacteriol. 1993, 175, 1191-1197.
30. Lichtenberg, D.; Barenholz, Y. Methods Biochem. Anal. 1988, 33, 337-462.
31. Elferink, M. G.; de Wit, J. G.; Driessen, A. J.; Konings, W. N. Biochim. Biophys. Acta 1994, 1193, 247-254.
32. Yamauchi, K.; Doi, K.; Kinoshita, M.; Ku, F.; Fukuda, H. Biochim. Biophys. Acta 1992, 1110, 171-177.
33. Choquet, C. G.; Patel, G. B.; Sprott, G. D. Can. J. Microbiol. 1996, 42, 183-186.
34. Zuidam, N. J.; Talsma, H.; Crommelin, D. J. A. In Handbook of non-medical applications of liposomes. From design to microreactors, Barenholz, Y.; Lasic, D., Ed.; CRC Press: 1996; pp. 71-80.
35. Patel, G. B.; Agnew, B. J.; Deschatelets, L.; Fleming, L. P.; Sprott, G. D. Int. JPharm. 2000, 194, 39-49.
36. Aramaki, Y.; Tomizawa, H.; Hara, T.; Yachi, K.; Kikuchi, H.; Tsuchiya, S. Pharm. Res. 1993, 10, 1228-1231.
37. Grit, M.; Zuidam, N. J.; Crommelin, D. J. A. In Liposome Technology, Gregoriadis, G., Ed.; CRC Press: Boca Raton, 1993; Vol. 1, pp. 455-486.
38. Richards, M. H.; Gardner, C. R. Biochim. Biophys. Acta 1978, 543, 508-522.
39. Rowland, R. N.; Woodley, J. F. Biochim. Biophys. Acta 1980, 620, 400-409.
40. Chiang, C.-M.; Weiner, N. Int. J. Pharm. 1987, 37, 75-85.
41. Allen, T. M.; Cleland, L. G. Biochim. Biophys. Acta 1980, 597, 418-426.
42. Senior, J. H. Crit Rev Ther. Drug Carrier Syst. 1987, 3, 123-193.
43. Allen, T. M. Adv. Drug Del. Rev. 1994, 13, 285-309.
44. Omri, A.; Makabi-Panzu, B.; Agnew, B. J.; Sprott, G. D.; Patel, G. B. J. Drug Target 2000, 7, 383-392.
45. Sprott, G. D.; Brisson, J.; Dicaire, C. J.; Pelletier, A. K.; Deschatelets, L. A.; Krishnan, L.; Patel, G. B. Biochim. Biophys. Acta 1999, 1440, 275-288.
46. Wassef, N. M.; Alving, C. R. Methods Enzymol. 1987, 149, 124-134.
47. Tolson, D. L.; Latta, R. K.; Patel, G. B.; Sprott, G. D. J. Liposome Res. 1996, 6, 755-776.
48. Moghimi, S. M.; Patel, H. M. Biochim. Biophys. Acta 1992, 1135, 269-274.
49. Richards, R. L.; Rao, M.; Wassef, N. M.; Glenn, G. M.; Rothwell, S. W.; Alving, C. R. Infect. Immun. 1998, 66, 2859-2865.
50. Harokopakis, E.; Hajishengallis, G.; Michalek, S. M. Infect. Immun. 1998, 66, 4299-4304.
51. Lachman, L. B.; Ozpolat, B.; Rao, X. M. Eur. Cytokine Netw. 1996, 7, 693-698.
52. Krishnan, L.; Dicaire, C. J.; Patel, G. B.; Sprott, G. D. Infect. Immun. 2000, 68, 54-63.
53. Sprott, G. D.; Tolson, D. L.; Patel, G. B. FEMS Microbiol. Lett. 1997, 154, 17-22.
54. Sprott, G. D.; Sad, S.; Fleming, L. P.; Dicaire, C. J.; Patel, G. B.; Krishnan, L. Archaea 2003, 1, 151-164.
55. Sprott, G. D.; Dicaire, C. J.; Gurnani, K.; Deschatelets, L. A.; Krishnan, L. Vaccine 2004, 22, 2154-2162.
56. Patel, G. B.; Zhou, H.; KuoLee, R.; Chen, W. J. Liposome Res. 2004, 14, 191-202.
57. Conlan, J. W.; Krishnan, L.; Willick, G. E.; Patel, G. B.; Sprott, G. D. Vaccine 2001, 19, 3509-3517.
58. Krishnan, L.; Sad, S.; Patel, G. B.; Sprott, G. D. Cancer Res. 2003, 63, 2526-2534.
59. Gurnani, K.; Kennedy, J.; Sad, S.; Sprott, G. D.; Krishnan, L. J. Immunol 2004, 173, 566-578.
60. Krishnan, L.; Sad, S.; Patel, G. B.; Sprott, G. D. J. Immunol. 2001, 166, 1885-1893.
61. Krishnan, L.; Sad, S.; Patel, G. B.; Sprott, G. D. J. Immunol. 2000, 165, 5177-5185.
62. Krishnan, L.; Sprott, G. D. J. Drug Target 2003, 11, 515-524.
63. Sprott, G. D.; Krishnan, L.; Conlan, J. W.; Omri, A.; Patel, G. B. PCT International Publication No. WO01/26683A2, 2001.
64. Pardoll, D. M. Nat. Med. 1998, 4, 525-531.
65. Pamer, E. G. Nat. Rev. Immunol. 2004, 4, 812-823.
66. Vijh, S.; Pamer, E. G. J. Immunol. 1997, 158, 3366-3371.
67. Lipford, G. B.; Lehn, N.; Bauer, S.; Heeg, K.; Wagner, H. Immunol Lett. 1994, 40, 101-104.
68. Moore, M. W.; Carbone, F. R.; Bevan, M. J. Cell 1988, 54, 777-785.
69. Shimada, H.; Nemoto, N.; Shida, Y.; Oshima, T.; Yamagishi, A. J. Bacteriol. 2002, 184, 556-563.
70. Pamer, E.; Cresswell, P. Annu. Rev. Immunol. 1998, 16, 323-358.
71. York, I. A.; Rock, K. L. Annu. Rev. Immunol. 1996, 14, 369-396.
72. Rigotti, A.; Acton, S. L.; Krieger, M. J. Biol. Chem. 1995, 270, 16221-16224.
73. Miller, T. L.; Wolin, M. J. Syst. Appl. Microbiol. 1986, 7, 223-229.
74. Brusa, T.; Canzi, E.; Allieve, L.; Del Puppo, E.; Ferrari, A. Curr. Microbiol. 1993, 27, 261-265.
75. Snyder, F. In Biochemistry of Lipids, Lipoproteins and Membranes, Vance, D. E.; Vance, J., Ed.; Elsevier Science Publishers B.V.: Amsterdam, 1991, pp. 241-267.
76. Stein, Y.; Halperin, G.; Leitersdorf, E.; Dabach, Y.; Hollander, G.; Stein, O. Biochim. Biophys. Acta 1984, 793, 354-364.
77. Derksen, J. T.; Baldeschwieler, J. D.; Scherphof, G. L. Proc. Natl. Acad. Sd. USA 1988, 85, 9768-9772.
78. Freisleben, H. J.; Neisser, C.; Hartmann, M.; Rudolph, P.; Geck, P.; Ring, K.; Muller, E. G. J. Liposome Res. 1993, 3, 817-833.
79. Omri, A.; Agnew, B. J.; Patel, G. B. Int. J Toxicol. 2003, 22, 9-23.
80. Claassen, E.; Westerhof, Y.; Versluis, B.; Kors, N.; Schellekens, M.; van Rooijen, N. Br. J. Exp. Pathol. 1988, 69, 865-875.
81. Allen, T. M.; Murray, L.; MacKeigan, S.; Shah, M. J. Pharmacol. Exp. Ther. 1984, 229, 267-275.
82. nd edition, Vol. 3. Interaction of Liposomes with the Biological Milieu.,Gregoriadis, G., Ed.; CRC Press: Boca Raton, 1993, pp. 345-383.
83. Stewart-Tull, D. E. S. In Immunological Adjuvants and Vaccines, Gregoriadis, G.; Allison, A. C.; Poste, G., Ed.; Plenum Press: New York, 1989, pp. 213-226.
84. Santos, W. R.; Bernardo, R. R.; Pecanha, L. M.; Palatnik, M.; Parente, J. P.; de Sousa, C. B. Vaccine 1997, 15, 1024-1029.
85. Choquet, C. G.; Patel, G. B.; Beveridge, T. J.; Sprott, G. D. Appl. Environ. Microbiol. 1992, 55, 2894-2900.